Aurobindo gets FDA approval for dorzolamide HCl and timolol maleate ophthalmic solution
EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application dorzolamide HCl and timolol maleate ophthalmic solution, 2% / 0.5%. Aurobindo Pharma’s dorzolamide HCl and timolol maleate ophthalmic solution, are an AT-rated generic equivalent to the reference listed drug (RLD), Cosopt Ophthalmic Solution,
